{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:03:49Z","timestamp":1750478629237,"version":"3.41.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Although the immunohistochemical expression of the transmembrane sialoglycoprotein podoplanin (D2-40) has been repeatedly reported as a factor of prognosis in various tumor entities\u2014its potential prognostic relevance in squamous cell carcinomas of the vulva remains to be evaluated. In the present study, we evaluated 68 patients with primary vulvar carcinomas (VC) and analyzed the cytoplasmic\/membranous immunohistochemical expression of podoplanin in viable tumor cells and cancer-associated fibroblasts (CAFs) within the adjacent peritumoral stroma. To determine potential associations between podoplanin expression and traditional clinicopathological parameters (e.g., tumor stage, infiltration depth, groin lymph node metastasis), as well as with local recurrences, metastases, and patient\u2019s overall survival, subsequent data analysis was conducted using Spearman correlation analysis, Fisher\u2019s exact test and the log-rank test (Mantel-Cox). Although our results did not substantiate a positive correlation of podoplanin expression in tumor cells or CAFs with traditional histomorphological parameters, we propose a prognostic potential of podoplanin as a tissue-based biomarker in HPV-associated VC. In our exploratory pilot study, we observed a significantly improved overall survival in this distinct subgroup (Log-rank (Mantel-Cox) test; <jats:italic>p<\/jats:italic>\u2009=\u20090.0399). The results of our retrospective study may support the expectations that podoplanin, a common and widely available antibody, could be used as a tool for prognostic purposes in the future. Further research and validation are necessary before these markers can be implemented in clinical practice.<\/jats:p>","DOI":"10.1038\/s41598-025-06908-8","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T14:17:35Z","timestamp":1750429055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of podoplanin expression in vulvar squamous cell carcinoma and stromal fibroblasts and its prognostic implications"],"prefix":"10.1038","volume":"15","author":[{"given":"Gilbert Georg","family":"Klamminger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meletios P.","family":"Nigdelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Bitterlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Parvanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Ertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Schn\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Holleczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Hasenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashar","family":"Haj Hamoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich Franz","family":"Solomayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"6908_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/cancers14020389","volume":"14","author":"L Bucchi","year":"2022","unstructured":"Bucchi, L., Pizzato, M., Rosso, S. & Ferretti, S. New insights into the epidemiology of vulvar cancer: Systematic literature review for an update of incidence and risk factors. Cancers 14, 389 (2022).","journal-title":"Cancers"},{"key":"6908_CR2","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/bjc.2013.273","volume":"109","author":"IS Rodrigues","year":"2013","unstructured":"Rodrigues, I. S. et al. Epithelial-mesenchymal transition-like events in vulvar cancer and its relation with HPV. Br. J. Cancer 109, 184\u2013194 (2013).","journal-title":"Br. J. Cancer"},{"key":"6908_CR3","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s00432-021-03715-2","volume":"148","author":"CE Brambs","year":"2022","unstructured":"Brambs, C. E. et al. Epithelial-mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement. J. Cancer Res. Clin. Oncol. 148, 1183\u20131193 (2022).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"6908_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.humpath.2022.05.009","volume":"126","author":"SY Zare","year":"2022","unstructured":"Zare, S. Y., Ciscato, A. & Fadare, O. Tumor budding activity is an independent prognostic factor in squamous cell carcinoma of the vulva. Hum. Pathol. 126, 77\u201386 (2022).","journal-title":"Hum. Pathol."},{"key":"6908_CR5","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1038\/bjc.2013.563","volume":"109","author":"MD Trietsch","year":"2013","unstructured":"Trietsch, M. D. et al. Spindle cell morphology is related to poor prognosis in vulvar squamous cell carcinoma. Br. J. Cancer 109, 2259\u20132265 (2013).","journal-title":"Br. J. Cancer"},{"key":"6908_CR6","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/ijc.23611","volume":"123","author":"A Kawase","year":"2008","unstructured":"Kawase, A. et al. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int. J. Cancer 123, 1053\u20131059 (2008).","journal-title":"Int. J. Cancer"},{"key":"6908_CR7","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1158\/0008-5472.CAN-10-3228","volume":"71","author":"A Hoshino","year":"2011","unstructured":"Hoshino, A. et al. Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: Podoplanin in fibroblast functions for tumor progression. Cancer Res. 71, 4769\u20134779 (2011).","journal-title":"Cancer Res."},{"key":"6908_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10549-012-1984-x","volume":"134","author":"SF Schoppmann","year":"2012","unstructured":"Schoppmann, S. F. et al. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer. Breast Cancer Res. Treat. 134, 237\u2013244 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"6908_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00428-010-0915-7","volume":"456","author":"M Kreppel","year":"2010","unstructured":"Kreppel, M., Scheer, M., Drebber, U., Ritter, L. & Z\u00f6ller, J. E. Impact of podoplanin expression in oral squamous cell carcinoma: Clinical and histopathologic correlations. Virchows Arch. 456, 473\u2013482 (2010).","journal-title":"Virchows Arch."},{"key":"6908_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00428-005-0133-x","volume":"448","author":"J Shibahara","year":"2006","unstructured":"Shibahara, J., Kashima, T., Kikuchi, Y., Kunita, A. & Fukayama, M. Podoplanin is expressed in subsets of tumors of the central nervous system. Virchows Arch. 448, 493\u2013499 (2006).","journal-title":"Virchows Arch."},{"key":"6908_CR11","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/cas.13580","volume":"109","author":"H Krishnan","year":"2018","unstructured":"Krishnan, H. et al. Podoplanin: An emerging cancer biomarker and therapeutic target. Cancer Sci 109, 1292\u20131299 (2018).","journal-title":"Cancer Sci"},{"key":"6908_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/PGP.0b013e31821f4de2","volume":"31","author":"RS Goes","year":"2012","unstructured":"Goes, R. S. et al. Intratumoral lymphatic vessel density in vulvar squamous cell carcinomas. Int. J. Gynecol. Pathol. 31, 8\u201314 (2012).","journal-title":"Int. J. Gynecol. Pathol."},{"key":"6908_CR13","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki. JAMA 310, 2191 (2013).","DOI":"10.1001\/jama.2013.281053"},{"key":"6908_CR14","unstructured":"Lokuhetty D, et al. Female Genital Tumours. WHO Classification of Tumours. (Internal Agency for Research on Cancer (IARC), 2020)."},{"key":"6908_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jop.13041","volume":"50","author":"FW Mello","year":"2021","unstructured":"Mello, F. W. et al. Prognostic and clinicopathological significance of podoplanin immunoexpression in oral and oropharyngeal squamous cell carcinoma: A systematic review. J. Oral Pathol. Med. 50, 1\u20139 (2021).","journal-title":"J. Oral Pathol. Med."},{"key":"6908_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s12253-013-9723-0","volume":"20","author":"S Seki","year":"2014","unstructured":"Seki, S. et al. Prognostic value of podoplanin expression in oral squamous cell carcinoma-a regression model auxiliary to UICC classification. Pathol. Oncol. Res. 20, 521\u2013528 (2014).","journal-title":"Pathol. Oncol. Res."},{"key":"6908_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.archoralbio.2016.05.008","volume":"69","author":"YS Hwang","year":"2016","unstructured":"Hwang, Y. S. et al. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma. Arch. Oral Biol. 69, 25\u201332 (2016).","journal-title":"Arch. Oral Biol."},{"key":"6908_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/jso.23238","volume":"107","author":"M Kreppel","year":"2013","unstructured":"Kreppel, M. et al. Podoplanin expression in cutaneous head and neck squamous cell carcinoma\u2014Prognostic value and clinicopathologic implications. J. Surg. Oncol. 107, 376\u2013383 (2013).","journal-title":"J. Surg. Oncol."},{"key":"6908_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/03936155221105524","volume":"37","author":"JP K\u00fchn","year":"2022","unstructured":"K\u00fchn, J. P. et al. Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patients. Int. J. Biol. Mark. 37, 280\u2013288 (2022).","journal-title":"Int. J. Biol. Mark."},{"key":"6908_CR20","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.oraloncology.2011.06.508","volume":"47","author":"M Kreppel","year":"2011","unstructured":"Kreppel, M. et al. Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy. Oral Oncol. 47, 873\u2013878 (2011).","journal-title":"Oral Oncol."},{"key":"6908_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12885-020-06936-9","volume":"20","author":"L Hu","year":"2020","unstructured":"Hu, L. et al. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis. BMC Cancer 20, 424 (2020).","journal-title":"BMC Cancer"},{"key":"6908_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/01478885.2020.1757872","volume":"43","author":"D G\u00fclseren","year":"2020","unstructured":"G\u00fclseren, D., G\u00f6k\u00f6z, \u00d6., Karahan, S. & Karaduman, A. Podoplanin expression in cutaneous squamous cell carcinomas and its relationship to histopathological prognostic factors. J. Histotechnol. 43, 147\u2013152 (2020).","journal-title":"J. Histotechnol."},{"key":"6908_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/cup.12859","volume":"44","author":"J Ca\u00f1ueto","year":"2017","unstructured":"Ca\u00f1ueto, J. et al. The expression of podoplanin is associated with poor outcome in cutaneous squamous cell carcinoma. J. Cutan. Pathol. 44, 144\u2013151 (2017).","journal-title":"J. Cutan. Pathol."},{"key":"6908_CR24","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/cas.13580","volume":"109","author":"H Krishnan","year":"2018","unstructured":"Krishnan, H. et al. Podoplanin: An emerging cancer biomarker and therapeutic target. Cancer Sci. 109, 1292\u20131299 (2018).","journal-title":"Cancer Sci."},{"key":"6908_CR25","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.1007\/s13277-014-2266-5","volume":"35","author":"N Swain","year":"2014","unstructured":"Swain, N., Kumar, S. V., Routray, S., Pathak, J. & Patel, S. Podoplanin\u2014a novel marker in oral carcinogenesis. Tumor Biol. 35, 8407\u20138413 (2014).","journal-title":"Tumor Biol."},{"key":"6908_CR26","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/S0049-3848(12)70013-0","volume":"129","author":"KL Lowe","year":"2012","unstructured":"Lowe, K. L., Navarro-Nunez, L. & Watson, S. P. Platelet CLEC-2 and podoplanin in cancer metastasis. Thromb. Res. 129, S30\u2013S37 (2012).","journal-title":"Thromb. Res."},{"key":"6908_CR27","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1242\/jcs.03218","volume":"119","author":"E Mart\u00edn-Villar","year":"2006","unstructured":"Mart\u00edn-Villar, E. et al. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J. Cell. Sci. 119, 4541\u20134553 (2006).","journal-title":"J. Cell. Sci."},{"key":"6908_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/1066896912471851","volume":"21","author":"MP Foschini","year":"2013","unstructured":"Foschini, M. P. et al. Podoplanin and E-cadherin expression in preoperative incisional biopsies of oral squamous cell carcinoma is related to lymph node metastases. Int. J. Surg. Pathol. 21, 133\u2013141 (2013).","journal-title":"Int. J. Surg. Pathol."},{"key":"6908_CR29","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/his.12496","volume":"66","author":"N Wakisaka","year":"2015","unstructured":"Wakisaka, N. et al. Induction of epithelial\u2013mesenchymal transition and loss of podoplanin expression are associated with progression of lymph node metastases in human papillomavirus-related oropharyngeal carcinoma. Histopathology 66, 771\u2013780 (2015).","journal-title":"Histopathology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06908-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06908-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06908-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T14:17:36Z","timestamp":1750429056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06908-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6908"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06908-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests pertaining to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20224"}}